(2S)-N-[(2S)-1-[(3S,3aS,6aR)-3-(6-cyclopropyl-5-oxo-3-propylhexanoyl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-cyclohexyl-4-oxo-4-pyrazin-2-ylbutanamide;deuterium monohydride;ethane
C43H72N4O5 — CID 163988523
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-N-[(2S)-1-[(3S,3aS,6aR)-3-(6-cyclopropyl-5-oxo-3-propylhexanoyl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-cyclohexyl-4-oxo-4-pyrazin-2-ylbutanamide;deuterium monohydride;ethane
(2S)-N-[(2S)-1-[(3S,3aS,6aR)-3-(6-cyclopropyl-5-oxo-3-propylhexanoyl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-cyclohexyl-4-oxo-4-pyrazin-2-ylbutanamide;deuterium monohydride;ethane (PubChem CID 163988523) has the molecular formula C43H72N4O5 and a molecular weight of 726.08 g/mol. Its IUPAC name is (2S)-N-[(2S)-1-[(3S,3aS,6aR)-3-(6-cyclopropyl-5-oxo-3-propylhexanoyl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-cyclohexyl-4-oxo-4-pyrazin-2-ylbutanamide;deuterium monohydride;ethane.
Molecular Properties
| Compound Name | (2S)-N-[(2S)-1-[(3S,3aS,6aR)-3-(6-cyclopropyl-5-oxo-3-propylhexanoyl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-cyclohexyl-4-oxo-4-pyrazin-2-ylbutanamide;deuterium monohydride;ethane |
|---|---|
| PubChem CID | 163988523 |
| Molecular Formula | C43H72N4O5 |
| Molecular Weight | 726.08 g/mol |
| Exact Mass | 725.56 |
| IUPAC Name | (2S)-N-[(2S)-1-[(3S,3aS,6aR)-3-(6-cyclopropyl-5-oxo-3-propylhexanoyl)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-3,3-dimethyl-1-oxobutan-2-yl]-2-cyclohexyl-4-oxo-4-pyrazin-2-ylbutanamide;deuterium monohydride;ethane |
| SMILES | CC.CC.CCCC(CC(=O)CC1CC1)CC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](CC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C.[H][2H] |
| InChI | InChI=1S/C39H58N4O5.2C2H6.H2/c1-5-10-26(20-29(44)19-25-15-16-25)21-34(46)35-30-14-9-13-28(30)24-43(35)38(48)36(39(2,3)4)42-37(47)31(27-11-7-6-8-12-27)22-33(45)32-23-40-17-18-41-32;2*1-2;/h17-18,23,25-28,30-31,35-36H,5-16,19-22,24H2,1-4H3,(H,42,47);2*1-2H3;1H/t26?,28-,30-,31-,35-,36+;;;/m0.../s1/i;;;1+1 |
| InChIKey | TYNFQTLZDYAMTO-CPZIDFFJSA-N |
| XLogP | 8.84 |
| TPSA | 126.40 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 52 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 726.08 |
| LogP ≤ 5 | 8.84 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163988523 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.